Showing results (1361-1370 of 9,422) with videos related to

Sort By:
Pageof 943
Clinical Endocrinology|September 21, 2006
Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patientsChristian Pötzi, Abbas Moameni, Georgios Karanikas, et al.
Clinical Endocrinology|August 1, 1990
The effect of galanin on baseline and GHRH-induced growth hormone secretion in obese childrenS Loche, S Pintus, S G Cella, et al.
Clinical Endocrinology|August 5, 2006
Serum ghrelin levels are suppressed in hypopituitary patients following insulin-induced hypoglycaemia irrespective of GH statusLouise Ryber, Kristina Obrink, Nanna Houe, et al.
Clinical Endocrinology|August 5, 2006
Dendritic cells as potential adjuvant for immunotherapy in adrenocortical carcinomaClaudia Papewalis, Martin Fassnacht, Holger S Willenberg, et al.
Clinical Endocrinology|August 5, 2006
Metabolic effects of caffeine ingestion and physical work in 75-year old citizens. A randomized, double-blind, placebo-controlled, cross-over studyC B Norager, M B Jensen, A Weimann, et al.
Clinical Endocrinology|August 5, 2006
Presentation and evolution of organic central precocious puberty according to the type of CNS lesionChristine Trivin, Ana-Claudia Couto-Silva, Christian Sainte-Rose, et al.
Clinical Endocrinology|August 22, 2006
Corticosteroids and the cardiovascular response to stress: a pilot study of the 35% CO2 challenge in Addison's diseaseJ M Kaye, S L Lightman
Clinical Endocrinology|August 22, 2006
The role of chromogranin A in the management of patients with phaeochromocytomaErika Grossrubatscher, Paolo Dalino, Federico Vignati, et al.
Clinical Endocrinology|August 22, 2006
Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatmentEllen M N Bannink, Jaap van Doorn, Theo Stijnen, et al.
Clinical Endocrinology|August 22, 2006
Efficacy of lanreotide Autogel administered every 4-8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: a phase III trialT Lucas, R Astorga,
Pageof 943